99 related articles for article (PubMed ID: 446978)
1. Effect of radiotherapy on lymphocyte cytotoxicity against allogeneic lung cancer cells in patients with bronchogenic carcinoma.
Toyohira K; Yasumoto K; Manabe H; Ohta M; Terashima H; Takayama K; Shinohara S; Nomoto K
Gan; 1979 Feb; 70(1):9-14. PubMed ID: 446978
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic activity of lymphocytes to bronchogenic carcinoma cells in patients with lung cancer.
Yasumoto K; Ohta M; Nomoto K
Gan; 1976 Aug; 67(4):505-11. PubMed ID: 1030675
[TBL] [Abstract][Full Text] [Related]
3. Effect of anticancer therapy of lymphocyte cytotoxicity in lung cancer patients.
Manabe H; Yasumoto K; Ohta M; Toyohira K; Nomoto K
Gan; 1977 Aug; 68(4):477-82. PubMed ID: 357239
[TBL] [Abstract][Full Text] [Related]
4. Cytostatic activity of peripheral blood monocytes against bronchogenic carcinoma cells in patients with lung cancer.
Yanagawa E; Yasumoto K; Manabe H; Nagano N; Hirota N; Ohta M; Hattori T; Nomoto K; Azuma I; Yamamura Y
Gan; 1979 Aug; 70(4):533-9. PubMed ID: 229054
[TBL] [Abstract][Full Text] [Related]
5. Microcytotoxicity assays of tumor immunity in patients with bronchogenic carcinoma correlated with clinical status.
Pierce GE; DeVald B
Cancer Res; 1975 Dec; 35(12):3577-84. PubMed ID: 1192421
[TBL] [Abstract][Full Text] [Related]
6. Antibody specific for lung cancer cells detected in sera of patients with bronchogenic carcinoma.
Yasumoto K; Manabe H; Nomoto K; Inokuchi K
Gan; 1983 Aug; 74(4):595-601. PubMed ID: 6628908
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of immune reactions against cultured hamartoma cells with lymphocytes from patients with bronchogenic carcinoma.
Pierce GE; Allingham R; Bell JW
Surg Forum; 1972; 23(0):89-91. PubMed ID: 4671035
[No Abstract] [Full Text] [Related]
8. [Immunologic disorders in lung malignancies and possibilities of immuno-corrective therapy].
Vucković Lj; Stanojević N; Rajner L; Susnjar S
Glas Srp Akad Nauka Med; 1991; (41):87-96. PubMed ID: 1916451
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic cell function in bronchogenic carcinoma.
Kratikanont P; deShazo RD; Banks DE; Chapman Y
Chest; 1987 Jul; 92(1):90-4. PubMed ID: 3595254
[TBL] [Abstract][Full Text] [Related]
10. Phenotype and function of natural killer cells in patients with bronchogenic carcinoma.
LeFever AV; Funahashi A
Cancer Res; 1991 Oct; 51(20):5596-601. PubMed ID: 1655257
[TBL] [Abstract][Full Text] [Related]
11. [Multitest evaluation of the immune status of patients with bronchogenic carcinoma before and after radiotherapy].
Gava A; Fontan L; Marazzato G; De Angeli S
Minerva Med; 1990 Mar; 81(3):135-8. PubMed ID: 2320281
[TBL] [Abstract][Full Text] [Related]
12. Regional and systemic CD4 and CD8 subsets in bronchogenic carcinoma.
Liss HP; Baumann MA; Paul CC; Payne CB
Neth J Med; 1991 Dec; 39(5-6):333-7. PubMed ID: 1687075
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte mitogen stimulation studies for patients with lung cancer: evaluation of prognostic significance of preirradiation therapy studies.
Dalbow MH; Concannon JP; Eng CP; Weil CS; Conway J; Narayanan Nambisan PT
J Lab Clin Med; 1977 Aug; 90(2):295-302. PubMed ID: 886214
[TBL] [Abstract][Full Text] [Related]
14. Immunoprofile studies for patients with bronchogenic carcinoma. I. Correlation of pretherapy studies with survival.
Liebler GA; Concannon JP; Magovern GJ; Dalbow MH; Hodgson SE
J Thorac Cardiovasc Surg; 1977 Oct; 74(4):506-18. PubMed ID: 302883
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous lymphokine activated killer (LAK) activity in bronchoalveolar lavage cells from patients with bronchogenic carcinoma.
Stein-Streilein J; Guffee J; Ramos M; Pitchenik AE
Reg Immunol; 1989; 2(6):370-5. PubMed ID: 2485685
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated cytotoxicity in vitro of human lymphocytes against a cervical cancer cell line.
Mashiba H; Matsunaga K; Ueno M; Jimi S
Gan; 1977 Feb; 68(1):53-8. PubMed ID: 558932
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of immunological tests in lung cancer.
Check IJ; Hunter RL; Karrison T; DeMeester TR; Golomb HM; Vardiman J
Clin Exp Immunol; 1981 Feb; 43(2):362-9. PubMed ID: 7023761
[TBL] [Abstract][Full Text] [Related]
18. Panel report. Radiotherapy for lung cancer.
Rubin P
Cancer Chemother Rep 3; 1973 Mar; 4(2):311-5. PubMed ID: 4729336
[No Abstract] [Full Text] [Related]
19. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
20. The recognition of human bronchogenic carcinomas.
Stark M; Stiller-Winkler R; Idel H; Schlipköter HW
Cancer Detect Prev; 1983; 6(1-2):167-72. PubMed ID: 6883377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
